T'SUMOYL

Non-medicated skin care preparations; cosmetic preparations for skin care; cosmetic preparations for skin care, based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic oils; cosmetic skin creams; skin care creams, lotions and oils for cosmetic purposes; wrinkle removing skin care preparations; cosmetic sunscreen preparations; waterproof sunscreen; sunscreen preparations; sunscreen creams and lotions; cosmetics for protecting the skin from sunburn; sunblock lotions; cosmetic sun barriers; sun creams; cosmetic preparations for protecting the skin from the sun's rays; sun care lotions; cosmetic compounds for skin care after exposure to the sun's rays; after-sun milks, creams, lotions and moisturizers; sun skin bronzers; sun-tanning preparations; cosmetics for tanning the skin including preparations for tanning without sunlight, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin including preparations for tanning without sunlight, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic self-tanning preparations; self -tanning creams and lotions for cosmetic purposes; suntan creams, lotions, oils and gels; non-medicated skin rejuvenation preparations, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels; non-medicated skin rejuvenation products, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels with and without analogues of alpha-melanocyte stimulating hormone (alpha-MSH); non-medicated antiaging skincare preparations; antiaging creams, lotions, moisturizers, gels, balms and serums; skin cleansing creams, lotions, milks, foams, gels and masks for cosmetic purposes

Pharmaceuticals for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceuticals for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical drugs for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical drugs for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical preparations for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds, all used for the delivery and storage of pharmaceuticals containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide